These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 852589)
61. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase. Wilke WL Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046 [TBL] [Abstract][Full Text] [Related]
62. Comparative and quantitative study of L-dopa decarboxylase mRNA in rat neuronal and non-neuronal tissues. Coge F; Krieger-Poullet M; Gros F; Thibault J Biochem Biophys Res Commun; 1990 Aug; 170(3):1006-12. PubMed ID: 2390071 [TBL] [Abstract][Full Text] [Related]
63. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. Opacka-Juffry J; Ashworth S; Ahier RG; Hume SP J Neural Transm (Vienna); 1998; 105(4-5):349-64. PubMed ID: 9720967 [TBL] [Abstract][Full Text] [Related]
64. Purification and properties of hog-kidney 3,4-dihydroxyphenylalanine decarboxylase. Lancaster GA; Sourkes TL Can J Biochem; 1972 Jul; 50(7):791-7. PubMed ID: 5050936 [No Abstract] [Full Text] [Related]
65. Some properties of dopa decarboxylase from Sarcophaga bullata. Chen T; Hodgetts RB Comp Biochem Physiol B; 1976; 53(3):415-8. PubMed ID: 3361 [No Abstract] [Full Text] [Related]
67. Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation. Kashihara Y; Terao Y; Yoda K; Hirota T; Kubota T; Kimura M; Matsuki S; Hirakawa M; Irie S; Ieiri I Eur J Clin Pharmacol; 2019 Mar; 75(3):351-361. PubMed ID: 30382297 [TBL] [Abstract][Full Text] [Related]
68. "Zipped Synthesis" by Cross-Metathesis Provides a Cystathionine β-Synthase Inhibitor that Attenuates Cellular H2S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model. McCune CD; Chan SJ; Beio ML; Shen W; Chung WJ; Szczesniak LM; Chai C; Koh SQ; Wong PT; Berkowitz DB ACS Cent Sci; 2016 Apr; 2(4):242-52. PubMed ID: 27163055 [TBL] [Abstract][Full Text] [Related]
69. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. Daidone F; Montioli R; Paiardini A; Cellini B; Macchiarulo A; Giardina G; Bossa F; Borri Voltattorni C PLoS One; 2012; 7(2):e31610. PubMed ID: 22384042 [TBL] [Abstract][Full Text] [Related]
70. The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats. Leppert PS; Cortese M; Fix JA Pharm Res; 1988 Sep; 5(9):587-91. PubMed ID: 3247321 [TBL] [Abstract][Full Text] [Related]
71. Sinemet-ferrous sulphate interaction in patients with Parkinson's disease. Campbell NR; Rankine D; Goodridge AE; Hasinoff BB; Kara M Br J Clin Pharmacol; 1990 Oct; 30(4):599-605. PubMed ID: 2291872 [TBL] [Abstract][Full Text] [Related]